Category: drug pricing

Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect

January 23, 2024 STAT Off Biotech, biotechnology, Business, cancer, drug development, drug prices, drug pricing, government agencies, Health, Human Health, legal, Life Sciences, Medicare, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout, White House

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Investigators fault Lilly plant for manufacturing issues

January 22, 2024 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, government agencies, Health, Human Health, legal, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The Senate health committee looks into its first subpoena in 40 years

January 19, 2024 STAT Off Biotech, biotechnology, Business, Congress, coronavirus, drug development, drug prices, drug pricing, finance, government agencies, Health, Human Health, legal, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The XBI comedown after JPM

January 18, 2024 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, finance, Health, Health Tech, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The big any-day-now biotech news we’re keeping an eye on

January 17, 2024 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, finance, Health, Health Tech, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, policy, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The four biotech stories you need to read this morning

January 16, 2024 STAT Off Biotech, biotechnology, Business, cancer, Congress, drug development, drug prices, drug pricing, FDA, finance, government agencies, Health, Human Health, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, policy, Politics, research, Science and Research, The Readout, vaccines

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Novartis reportedly decides to pass on Cytokinetics

January 12, 2024 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, government agencies, Health, Human Health, legal, Life Sciences, Medicine, mental health, Pharma, Pharmaceuticals, Politics, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The highs — and lows — of JPM 2024 you should pay attention to

January 11, 2024 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, genetics, global health, Health, Health Tech, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…

JPM Day 3 had a cautiously optimistic outlook

January 10, 2024 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, Health, Health Tech, hospitals, Human Health, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, Politics, Science and Research, The Readout

In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…

JPM Day 2 has arrived. Here are the can’t-miss moments of the event so far

January 9, 2024 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug pricing, FDA, finance, genetics, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, physicians, research, Science and Research, The Readout

In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…

This is the TLDR of JPM Day 1

January 8, 2024 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, Health, health care, Health Tech, Human Health, jpm, JPM 2024, Life Sciences, Medicine, mental health, Pharma, Pharmaceuticals, public health, rare diseases, research, Science and Research, The Readout, Uncategorized

In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…

Why CG Oncology will be the first test of 2024’s IPO waters

January 4, 2024 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, government agencies, Health, Human Health, legal, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Anavex’s slow journey to failure

January 3, 2024 STAT Off advocacy, Biotech, biotechnology, Business, drug development, drug prices, drug pricing, finance, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

STAT+: 3 issues to watch in pharma in 2024

December 27, 2023 STAT Off 3 to watch, Biotech, drug pricing, Human Health, Life Sciences, Medicine, obesity, Pharma, Pharmaceuticals, Pharmalot, Science and Research, STAT+

As another year comes to an end and the world seems to hit the proverbial…

Morning Rounds: Our newsroom’s favorite stories of 2023

December 22, 2023 STAT Off Biotech, cancer, children's health, coronavirus, CRISPR, drug development, drug prices, drug pricing, finance, genetics, government agencies, Health, health disparities, hospitals, Human Health, insurance, legal, Life Sciences, Medicare, Medicine, Morning Rounds, Pharmaceuticals, physicians, public health, research, Science and Research, vaccines

Understand how science, health policy, and medicine shape the world everyday. Sign up for our…

The clock is ticking, and cytokinetics is running out of December

December 22, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, Health, Human Health, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

BioMarin appeases an activist

December 21, 2023 STAT Off Biotech, biotechnology, Business, cancer, CRISPR, drug development, drug prices, drug pricing, FDA, finance, genetics, government agencies, Health, Human Health, legal, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, physicians, rare diseases, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The biotech updates you need to read today

December 19, 2023 STAT Off Biotech, biotechnology, Business, cancer, drug development, drug prices, drug pricing, finance, genetics, Health, hospitals, Human Health, legal, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive

December 18, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, Health, Human Health, legal, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, physicians, rare diseases, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

FDA chastens pet companies over antibiotics

December 15, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Is it time to worry about Moderna?

December 14, 2023 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, finance, genetics, Health, Human Health, Life Sciences, Medicine, obesity, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

A plot to solve the ‘whack-a-mole’ of drug discovery

December 13, 2023 STAT Off Biotech, biotechnology, Business, CRISPR, drug pricing, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, public health, rare diseases, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Morning Rounds: Can you take GLP-1 drugs during pregnancy?

December 12, 2023 STAT Off addiction, Biotech, biotechnology, Business, Congress, drug development, drug pricing, Health, Human Health, Life Sciences, Medicine, mental health, Morning Rounds, patients, Pharma, Pharmaceuticals, research, Science and Research

Understand how science, health policy, and medicine shape the world everyday. Sign up for our…

Tome Biosciences goes public today in another biotech megaround

December 12, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, genetics, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, policy, rare diseases, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The biotech news you missed from the weekend

December 11, 2023 STAT Off Biotech, biotechnology, Business, cancer, drug development, drug pricing, FDA, finance, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds

December 11, 2023 STAT Off Biotech, drug pricing, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Pharmalot, Science and Research, STAT+

During 2022, drugmakers substantially raised prices on eight widely used medicines without any new clinical…

CRISPR is about to make history. Here’s the 5-minute rundown of what to expect

December 8, 2023 STAT Off Biotech, biotechnology, Business, coronavirus, CRISPR, drug development, drug prices, drug pricing, FDA, genetics, Health, Human Health, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, Politics, rare diseases, research, Science and Research, The Readout, vaccines

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Eli Lilly’s latest $1.4 billion deal might come unglued

December 7, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, finance, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout, vaccines

Want to stay on top of the science and politics driving biotech today? Sign up to get…

STAT+: U.S. judge orders Minnesota to pause its drug pricing transparency law over constitutional issues

December 6, 2023 STAT Off Biotech, drug pricing, Human Health, legal, Life Sciences, Medicine, Pharma, Pharmaceuticals, Pharmalot, Science and Research, STAT+, states

In a victory for the pharmaceutical industry, a U.S. judge ruled that Minnesota must temporarily…

Why Cerevel Therapeutics has risen 50% in three days without changing anything

December 6, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, global health, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

STAT+: $100 billion estimate for Ozempic-style weight loss drugs gets wary eye from analysts

December 5, 2023 STAT Off Biotech, drug development, drug pricing, Human Health, Life Sciences, Medicine, obesity, Pharmaceuticals, Science and Research, STAT+

NEW YORK — Will the world actually soon spend $100 billion a year on the…

Carmot’s chance of beating the odds in the biotech market just ended

December 5, 2023 STAT Off Biotech, biotechnology, Business, cancer, children's health, Congress, drug development, drug prices, drug pricing, FDA, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, policy, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Novartis is building a new radioligand plant in China

December 4, 2023 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, FDA, finance, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Johnson & Johnson bets heavy on AI-driven drug discovery

December 1, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug pricing, FDA, genetics, government agencies, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Do GLP-1s have a future treating alcoholism?

November 30, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, genetics, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

STAT+: Vertex pushes a donation program to widen access to cystic fibrosis treatments, but advocates say it’s not enough

November 28, 2023 STAT Off advocacy, Biotech, drug pricing, global health, Human Health, Life Sciences, Medicine, patents, Pharma, Pharmaceuticals, Pharmalot, Science and Research, STAT+, Vertex

Vertex Pharmaceuticals is being accused by a group of advocates and physicians of refusing to…

Today’s biotech news roundup, in under 800 words

November 28, 2023 STAT Off Alzheimer's disease, Alzheimer’s, Biotech, biotechnology, dementia, drug development, drug prices, drug pricing, FDA, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

A new algorithm unveils CRISPR ‘treasure trove’

November 27, 2023 STAT Off artificial intelligence, Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, finance, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Medtronic isn’t afraid of Wegovy’s potential to disrupt

November 22, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, government agencies, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Bayer’s new CEO was dealt a duo of ‘clearing events.’ Tough choices lie ahead

November 21, 2023 STAT Off Alzheimer's disease, Alzheimer’s, Biotech, biotechnology, Business, drug development, drug prices, drug pricing, finance, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout, vaccines

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Merck cough drug doesn’t pass panel scrutiny

November 20, 2023 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug pricing, FDA, government agencies, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

STAT+: U.K., pharma industry strike deal for how the NHS pays for medicines

November 20, 2023 STAT Off Biotech, drug pricing, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, policy, Science and Research, STAT+

LONDON — The U.K. and the pharmaceutical industry have reached a deal on a five-year…

The return of biotech’s “bump factor” amid an economic downturn

November 17, 2023 STAT Off Biotech, biotechnology, Business, CRISPR, drug development, drug pricing, FDA, finance, genetics, Health, health care, Human Health, Life Sciences, Medicine, Pharmaceuticals, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The apparently strong correlation between biotech stocks and the price of eggs, explained

November 15, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug pricing, finance, government agencies, health care, Human Health, Life Sciences, Medicine, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Novo Nordisk has its sights on becoming a major player in heart disease

November 13, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, finance, global health, Health, Human Health, Life Sciences, Medicine, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

BioMarin’s new CEO inherits a profitable company, a pioneering gene therapy, and a brewing activist challenge

November 8, 2023 STAT Off Biotech, biotechnology, cancer, drug pricing, finance, genetics, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, public health, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Your morning biotech news roundup

November 7, 2023 STAT Off Biotech, biotechnology, CRISPR, drug development, drug prices, drug pricing, FDA, finance, global health, government agencies, Health, health care, Human Health, Life Sciences, Medicine, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

XBI biotech index rises, giving investors a shred of hope

November 6, 2023 STAT Off Biotech, biotechnology, drug development, drug prices, drug pricing, finance, Health, health care, Human Health, Life Sciences, Medicine, Pharma, public health, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Shrinking COVID vaccine sales has Moderna course-correcting

November 3, 2023 STAT Off Biotech, biotechnology, Congress, drug development, drug prices, drug pricing, FDA, finance, Health, health care, Human Health, insurance, Life Sciences, Medicare, Medicine, Pharma, Pharmaceuticals, policy, Politics, public health, research, Science and Research, The Readout, vaccines

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis

November 2, 2023 STAT Off Biotech, biotechnology, Business, drug development, drug pricing, FDA, finance, Health, health care, Human Health, insurance, Life Sciences, Medicine, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get…